Strides Shasun gets USFDA nod for anti-allergy capsules
New Delhi: Strides Shasun on Monday said it has received approval from the US Food and Drug Administration for cetirizine hydrochloride capsules, used to relieve allergy symptoms.
In a BSE filing, Strides Shasun said, "It has received approval from the US FDA for cetirizine hydrochloride capsules, 10mg (liquid filled capsules OTC)".
The company said the product will be manufactured at its facility in Bengaluru and is ready for launch.
Quoting IRI data, Strides Shasun said the US market for cetirizine hydrochloride capsules is approximately $ 60 million, with only one other generic player.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd